CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ORIC — Oric Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ORIC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,340,823
-$324,995 QoQ
Shares Held
677,823
+12.0% QoQ
Ownership
0.654%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 179 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ORIC ranks #117 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ORIC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,340,823 | 677,823 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,665,818 | 605,037 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,080,483 | 621,086 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,238,484 | 603,207 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,881,248 | 382,389 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,279,457 | 408,505 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,372,896 | 417,955 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,204,847 | 410,229 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,147,927 | 162,366 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,437,480 | 104,544 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $980,729 | 106,601 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $640,586 | 105,882 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $821,644 | 105,882 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $94,922 | 16,653 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $98,086 | 16,653 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $53,289 | 16,653 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $646,540 | 144,317 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,150,839 | 215,513 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,299,135 | 224,431 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,592,986 | 219,655 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,314,117 | 130,815 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,805,323 | 114,503 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,713,785 | 109,713 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,322,428 | 52,876 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,812,043 | 53,722 | Shares | Sole | 2020-08-20 | |
| No filing history on record for this holder in this stock. | ||||||